Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)

keywords

  • Life Sciences & Biomedicine
  • Science & Technology

WoS ID

  • 000209470500025

volume

  • 47